A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Management of maternal cardiac arrest (MCA) among health care providers is significantly improved by Obstetric Life Support (OBLS) education, according to a recent study published in JAMA Network Open.1
MCA occurs in 1 in 3885 patients admitted for delivery, with evidence-based practices recommended for management by the American Heart Association. In the United States, there are currently no specific training requirements for MCA despite the country having a significant maternal mortality rate of 22.3 per 100,000 live births.2
While the current survival rate for MCA is estimated at 16%, this rate can be significantly improved by optimizing the chain of survival.1 Therefore, it may be vital to reduce gaps in provider knowledge and skills related to MCA. OBLS is a training program designed to provide health care professionals with these skills.
To evaluate the impact of OBLS toward efficacy of MCA management among health care professionals, investigators conducted a randomized clinical trial. Research coordinators performed data collection while data analyses were conducted by a biostatistician.
English-speaking health care professionals aged over 18 years working with reproductive-aged women in a prehospital or in-hospital environment were eligible for inclusion. Prehospital OHS education included a maximum of 4 participants per class across 2 crews, while hospital OHS education included a maximum of 6 participants.
Participants were assigned 1:1 to receive either OHS education or no education, with randomization stratified by hospital status. Cognitive and confidence evaluations were performed at enrollment for individuals in the OHS arm, alongside additional evaluations after intervention time, 6 months after enrollment, and 12 months after enrollment.
In the control group, participants received evaluations at enrollment and at 6 months after enrollment. Then, a third evaluation occurred after another 6 months following intervention.
The OBLS was defined as a “comprehensive, interdisciplinary, simulation-based training curriculum on MCA prevention and treatment based on the accepted evidence-based guidelines from the American Heart Association.” Participants needed an evaluation score of 70% or higher to pass.
Demographic and baseline data was collected. The cognitive score at time 1, defined as enrollment for controls and after the intervention for cases, was reported as the primary outcome. Megacode scores during time 1 were also a primary outcome. Additional evaluation scores were reported as secondary outcomes.
There were 46 participants aged a mean 41.1 years included in the analysis. Of participants, 7% were Asian, 7% Black, 2% Hispanic, 58% White, and 2% other. Experience as a simulation instructor was reported by only 37%.
Aside from 2 participants in the control group being certified in Advanced Trauma Life Support vs 0 in the intervention group, similar baseline characteristics were reported between groups. This included experience as a simulation, advanced cardiac life support, or Basic Life Support instructor.
The intervention group had a higher mean cognitive score compared to the control group, at 79.5% vs 63.4%, respectively. Similarly, megacode scores were 91% vs 61%, respectively, indicating a significant increase among patients receiving the intervention.
Finally, assessment pass rates were 90% and 10%, respectively, and mean confidence scores were 13.3 and 17.9 points, respectively. In the control group, confidence scores increased after OBLS education and at 6 months, at 24.3 and 20.6 points, respectively.
These results indicated improved readiness among health care professionals for managing MCA following an OBLS program intervention. Investigators concluded broader implementation of resuscitation training is necessary to prepare health care professionals for maternal medical emergencies.
Reference
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More